G. Borgherini - Vol. 7, Settembre 2001, num.3
Testo Immagini Bibliografia Summary Riassunto Indice
La remissione come end-point clinico nella comorbidità
depressione-ansia
Remission as a clinical end-point in
anxiety-depression comorbidity
1 Thase ME, Rush AJ. Treatment resistant depression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York, NY: Raven Press 1995:1081-97.
2 Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49:809-16.
3 Lavori PW, Keller MB, Mueller TI, et al. Time to recovery, chronicity and levels of psychopathology in major depression: an observational follow-up study of clinical predictors and somatic treatment as a mediating factor. Int J Meth Psychiatry 1994;4:211-29.
4 Shea MT, Elkin I, Imber SD, et al. Course of depressive symptoms over follow-up: findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program.
5 Angst J, Preisg M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients: results of a prospective study from 1959 to 1985. Schw Arch Neurol Psychiatry.
6 Lee AS, Murray RM. The long-term outcome of Maudsley depressives. Br J Psychiatry 1988;153:741-51.
7 Wells KB, Steward A, Hays RD, et al. The functioning and well being of depressed patients: results from the Medical Outcomes Study. J Am Med Ass 1989;262:914-9.
8 Judd L, Akiskal H, Paulus M. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Dis 1997;45:5-18.
9 Frank E, Prien RF, Jarret RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-5.
10 Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
11 U.S. Department of Health and Human Services. Depression Guideline Panel. In: Depression in primary care. Volume 2. Treatment of major depression. Clinical Practice Guideline N. 5. Rockville, MD. AHCPR Publication 1993.
12 Horwath E, Johnson J, Klerman GL, et al. Depressive symptoms as relative and attributable risk factors for first-onset major depression. Arch Gen Psychiatry 1992;49:817-23.
13 Thase ME. Long-term treatments of recurrent depressive disorders. J Clin Psychiatry 1992;53:32-44.
14 Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorders. Am J Psychiatry 1992;149:999-1010.
15 Thase ME. Understanding depression: a long term, recurring disorder. J Clin Psychiatry 2001;62:388-92.
16 Trivedi MH, Kleiber BA. Algorithm for the treatment of chronic depression. J Clin Psychiatry 2001;62:22-9.
17 Nobler MS, Roose SP. Differential response to antidepressants in melanconic and severe depression. Psychiatry Ann 1998;28:84-8.
18 Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
19 Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int J Psychopharmacol 1996;11:89-95.
20 Blazer DG, Hughes D, George LK, et al. Generalized anxiety disorder. In: Robins LN, Regier DA, eds. Psychiatric Disorders in America. New York, NY: The Free Press, Mac Millan 1991:180-203.
21 Wittchen HU, Zhao S, Kessler RC, et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:355-64.
22 Wittchen H-U, Kessler RC, Pfister H, Lieb M. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand 2000;102(Suppl.406):14-23.
23 Borgherini G, Comacchio A, Cintolo T, et al. Studio epidemiologico sui disturbi dell’umore con la CIDI 2.1 mediante computer-assisted interview (CATI) nel Comune di Padova. Giorn Ital Psicopat 2000;6:107.
24 Barlow DH, Blanchard EB, Vermilyea V, et al. Generalized anxiety and generalized anxiety disorder: description and reconceptualization. Am J Psychiatry 1986;143:40-4.
25 de Ruiter C, Rijken H, Garssen B, et al. Comorbidity among the anxiety disorders. J Anxiety Dis 1989;3:57-68.
26 Masi G, Mucci M, Favilla L, et al. Symptomatology and comorbidity of generalized anxiety disorder in children and adolescent. Comprehensive Psychiatry 1999;40:210-5.
27 Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994;151:640-9.
28 Massion AO, Warhaw MG, Keller MB. Quality of life and psychiatry morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry 1993;150:600-7.
29 Roy-Byrne PP, Katon W. Generalized anxiety disorder in primary care: the precursor/modifier pathway to increased health care utilization. J Clin Psychiatry 1997;58:34-8.
30 Angst J, Vollrath M. The natural history of anxiety disorders. Acta Psychiatr Scand 1991;159:23-33.
31 Wittchen HU, Essau CA, Krieg JC. Anxiety disorders: similarities and differences of comorbidity in treated and untreated groups. Br J Psychiatry 1991;159:23-33.
32 Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J Cons Clin Psychol 1992;60:835-44.
33 Ormel J, Oldehinkel T, Brillman E, et al. Outcome of depression and anxiety in primary care: a three-wave 3 1/2 -year study of psychopathology and disability. Arch Gen Psychiatry 1993;50:759-66.
34 Kessler RC, Du Pont RL, Paulus MP, et al. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry 1999;156:1915-23.
35 Sherbourne CD, Wells KB, Meredith LS, et al. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psichiatry 1996;53:889-95.
36 Maier W, Gansicke M, Freyberger HJ, et al. Generalized Anxiety Disorder (ICD-10) in primay care from a cross-cultural perspective: a valid diagnostic entity? Acta Psychiatr Scand 2000;101:29-36.
37 Shweizer E. Generalized anxiety disorder: longitudinal course and pharmacological treatment. Psych Clin Northern Am 1995;18:843-57.
38 Davidson JRT. Pharmacotherapy of General Anxiety Disorder. J Clin Psychiatry 2001;62:46-50.
39 Hoehn-Saric R, McLeod DR, Zimmerli WD. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatry 1988;49:293-301.
40 Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone and diazepam. Arch Gen Psychiatry 1993;50:884-95.
41 Hedges DW, Reimherr FW, Strong RE, et al. An open trial of nefazodone in adult patients with generalized anxiety disorder. Psychopharmacology Bulletin 1996;32:671-6.
42 Rocca P, Fonzo V, Scotta M, et al. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997;95:444-50.
43 Pollack MH, Zaninelli R, Goddard A, et al. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001;62:350-7.
44 Davidson JRT, DuPont RL, Hedges D, et al. Efficacy, safety and tollerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999;60:528-35.
45 Rickels K, Pollock MH, Sheehan DV, et al. Efficacy of extended release venlafaxine in non depressed outpatients with generalized anxiety disorder. Am J Psychiatry 2000;157:968-74.
46 Gelenberg AJ, Lydyard RB, Rudolph R, et al. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6 month randomized controlled trial. JAMA 2000;282:3082-8.
47 Hackett D. Venlafaxine XR in the treatment of anxiety. Acta Psychiatr Scand 2000;102(Suppl.406):30-35.
48 Lenderking W, Tennen H, Nackley JF, et al. The effects of venlafaxine on social activity level in depressed outpatients. J Clin Psychiatry 1999;60:157-63.
49 Thase ME, Entsuah RA, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-41.